Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Sites”

514 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 514 results

Not applicableStudy completedNCT07651423
What this trial is testing

Evaluating the Effect of Blue m Gel on Healing of Palatal Donor Site Versus Using Diode Laser

Who this might be right for
Free Gingival GraftLaser
Delta University for Science and Technology 40
Not applicableStudy completedNCT03589235
What this trial is testing

Platelet-Rich Fibrin Dressing in the Management of Free Gingival Graft

Who this might be right for
Gingival Recession
Damascus University 20
Not applicableStudy completedNCT02210208
What this trial is testing

A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.

Who this might be right for
Burn InjurySkin Graft
Molnlycke Health Care AB 25
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Not applicableWithdrawnNCT00389753
What this trial is testing

Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure

Who this might be right for
Hydration of Scars
University Hospital, Ghent
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT02865902
What this trial is testing

Low-level Laser Therapy in Enhancing Wound Healing and Preserving Tissue Thickness

Who this might be right for
Wounds
Karadeniz Technical University 40
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Not applicableStudy completedNCT01993030
What this trial is testing

Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site Wounds

Who this might be right for
Donor Site Wound
Zhejiang Xingyue Biotechnology Co., Ltd. 71
Early research (Phase 1)Active Not RecruitingNCT04013685
What this trial is testing

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more
Orca Biosystems, Inc. 155
Not applicableStudy completedNCT03000426
What this trial is testing

Photobiomodulation of Palatal Donor Site After Free Gingival Graft Removal

Who this might be right for
Palatal Wound
Universidade Estadual Paulista Júlio de Mesquita Filho 45
Not applicableWithdrawnNCT04749940
What this trial is testing

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site

Who this might be right for
Treatment of Skin Graft Donor Site
Rambam Health Care Campus
Testing effectiveness (Phase 2)Study completedNCT01186809
What this trial is testing

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Who this might be right for
Hematologic Malignancies
A.O. Ospedale Papa Giovanni XXIII 74
Not applicableUnknownNCT00964470
What this trial is testing

Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery

Who this might be right for
Treatment of Donor Site Burns
Aubrey Inc. 60
Not applicableLooking for participantsNCT06892496
What this trial is testing

Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques

Who this might be right for
Mucosal ErosionGingival Recession
Virginia Commonwealth University 56
Not applicableStudy completedNCT00003196
What this trial is testing

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more
Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT02248597
What this trial is testing

Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

Who this might be right for
Graft Versus Host DiseaseHematopoietic/Lymphoid Cancer
Wake Forest University Health Sciences 27
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Next Page